China's World Trade Organization accession has paved the way for many foreign investors to explore even more opportunities for investment into People’s Republic of China and Hong Kong. The penetration of PRC into the world market has also facilitated Chinese enterprises spreading their presence beyond the PRC.

 While we offer clients a unique and sophisticated international practice and our clientele spans the globe, we have a particular concentration of experience in the Asia Pacific region, with a significant proportion of our clientele hailing from the PRC. 

 We are one of a few U.S. firms with a group dedicated to the needs of Chinese businesses operating in the PRC.  We have a team of attorneys and supporting staff who is bilingual in Mandarin (Chinese) and English.  Our experienced corporate and securities team is familiar with the Chinese corporate and securities legal framework and is able to assist in the seamless transition of PRC companies into U.S. reporting companies.

Our Asian Practice Group aims to assist our clients to achieve their business objectives and goals, be they foreign investors going into the PRC or Chinese enterprises going abroad in the most efficient manner. It is also our ambition to raise the level of awareness amongst the business community on the importance of and the need to comply with the corporate governance requirements and business regulations.

In addition to our extensive network of PRC counsel, we work closely with other U.S. and Chinese-based professionals and service providers to provide a one-stop service center to our clients.

Services

PRC to the U.S.: Public Offerings and Reverse Mergers – We counsel PRC companies seeking to go public in the U.S. through traditional public offerings and reverse mergers. We provide our clients with a comprehensive range of services, including: sourcing a suitable shell, preparing all necessary Securities and Exchange Commission filings, selecting a suitable investor relations firm, and preparing for an exchange listing. We understand the process and complexities of going from a private company in the PRC to a public company in the U.S.  For example, we are current with latest implementing regulations from SAFE requiring central MOFCOMM and/or CSRC approvals for certain transactions.  We also focus on educating and preparing our clients so they will be poised for success from the start. In addition, we are able to assist in the continuing reporting obligations of our clients and advise them on all corporate compliance and regulatory matters in their new role as a U.S. public company.
 

U.S. to PRC: Investment Counseling –We counsel and assist hedge funds and other investors seeking to invest in the PRC, whether through a Wholly Owned Foreign Entity (“WFOE”), a traditional joint venture arrangement, a contractual arrangements and more recently, even through a gradual transition of corporate shareholdings. We make sure clients’ rights are protected and implement tight controls over the monies invested to ensure the investment is used for the intended purposes.
 

Representative Clients

 Our Asian Practice Group clients hail from various industries thoughout the PRC ranging from pharmaceuticals to education, travel to renewable resources.  Some of our clients are:

 Shengkai Innovations, Inc. (SKII)
 Universal Travel Group (UTVG)
 China Education Alliance Inc. (CEUA)
 Universal Fog, Inc. (UFOG)
 Aida Pharmaceuticals, Inc.  (AIDA)
 China Sun Group Hi-Tech Co. (CSGH)
 Long-e International, Inc. (PK)
 China Wind Systems, Inc.  (CWSI)
 China Carbon Graphite Group (CHGI)

Pre-OTCBB:

China Donghang Printing Technology Inc. (www.china-donghang.com)
Fangxing Tehcnology Development Co., Ltd (www.fangxingpharma.com)
Shandong Zhongshan Pulp & Paper Co., Ltd
Harbin Xinda Macromolecule Material Co., Ltd.
Sanming Huajian Bio-Engineering Co., Ltd.
Taiyuan Hong Xong Carbon Black Co., Ltd
Transn Information Technology Co., Ltd
Guangdong Haoxun Information Technology Co., Ltd
Taiyuan Hongxiong Carbon Black Co., Ltd.

Transactions

 SRFF was rated the No. 1 2008 PIPE Market Issuer Counsel with 26 completed PIPE transaction through September 30, 2008 involving a total amount of over $130,000,000.  The Asian Practice Group played an integral role in achieving this milestone.  Among these transactions include advising on a $20 million raise for Shengkai Innovations Inc. (OTCBB: SKII) and a $7.5 million private placement for Universal Travel Group (OTCBB: UTVG) in 2008. We have also acted as Placement Agent counsel for a $30 million raise for China Valve Technology, Inc. (OTCBB: CVVT) and have represented the placement agent in a $10 million raise for Yongye Biotechnology International Inc.